Annual CFF
$35.60 M
+$24.20 M+212.22%
31 December 2023
Summary:
Tempest Therapeutics annual cash flow from financing activities is currently $35.60 million, with the most recent change of +$24.20 million (+212.22%) on 31 December 2023. During the last 3 years, it has risen by +$1.00 million (+2.90%). TPST annual CFF is now -39.72% below its all-time high of $59.06 million, reached on 31 December 2021.TPST Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$1.54 M
-$3.02 M-66.18%
30 September 2024
Summary:
Tempest Therapeutics quarterly cash flow from financing activities is currently $1.54 million, with the most recent change of -$3.02 million (-66.18%) on 30 September 2024. Over the past year, it has increased by +$1.52 million (+7238.10%). TPST quarterly CFF is now -96.24% below its all-time high of $40.96 million, reached on 30 June 2021.TPST Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$40.90 M
+$1.52 M+3.86%
30 September 2024
Summary:
Tempest Therapeutics TTM cash flow from financing activities is currently $40.90 million, with the most recent change of +$1.52 million (+3.86%) on 30 September 2024. Over the past year, it has increased by +$44.37 million (+1277.57%). TPST TTM CFF is now -30.77% below its all-time high of $59.07 million, reached on 30 September 2021.TPST TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TPST Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +212.2% | +7238.1% | +1277.6% |
| 3 y3 years | +2.9% | -51.3% | -30.8% |
| 5 y5 years | - | - | - |
TPST Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -39.7% | +212.2% | -95.5% | +132.6% | -30.8% | +1277.6% |
| 5 y | 5 years | -39.7% | +212.2% | -96.2% | +132.6% | -30.8% | +1277.6% |
| alltime | all time | -39.7% | +212.2% | -96.2% | +132.6% | -30.8% | +1277.6% |
Tempest Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.54 M(-66.2%) | $40.90 M(+3.9%) |
| June 2024 | - | $4.56 M(+912.7%) | $39.38 M(+9.4%) |
| Mar 2024 | - | $450.00 K(-98.7%) | $36.01 M(+1.1%) |
| Dec 2023 | $35.60 M(+212.2%) | $34.35 M(>+9900.0%) | $35.60 M(-1125.1%) |
| Sept 2023 | - | $21.00 K(-98.2%) | -$3.47 M(+10.5%) |
| June 2023 | - | $1.19 M(+2600.0%) | -$3.14 M(-131.3%) |
| Mar 2023 | - | $44.00 K(-100.9%) | $10.04 M(-11.9%) |
| Dec 2022 | $11.40 M | -$4.73 M(-1450.3%) | $11.40 M(-29.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $350.00 K(-97.6%) | $16.12 M(-14.9%) |
| June 2022 | - | $14.38 M(+924.7%) | $18.94 M(-58.4%) |
| Mar 2022 | - | $1.40 M(<-9900.0%) | $45.52 M(-22.9%) |
| Dec 2021 | $59.06 M(+70.7%) | -$9000.00(-100.3%) | $59.06 M(-0.0%) |
| Sept 2021 | - | $3.17 M(-92.3%) | $59.07 M(+5.7%) |
| June 2021 | - | $40.96 M(+174.1%) | $55.91 M(+274.1%) |
| Mar 2021 | - | $14.94 M | $14.94 M |
| Dec 2020 | $34.60 M | - | - |
FAQ
- What is Tempest Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Tempest Therapeutics?
- What is Tempest Therapeutics annual CFF year-on-year change?
- What is Tempest Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Tempest Therapeutics?
- What is Tempest Therapeutics quarterly CFF year-on-year change?
- What is Tempest Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Tempest Therapeutics?
- What is Tempest Therapeutics TTM CFF year-on-year change?
What is Tempest Therapeutics annual cash flow from financing activities?
The current annual CFF of TPST is $35.60 M
What is the all time high annual CFF for Tempest Therapeutics?
Tempest Therapeutics all-time high annual cash flow from financing activities is $59.06 M
What is Tempest Therapeutics annual CFF year-on-year change?
Over the past year, TPST annual cash flow from financing activities has changed by +$24.20 M (+212.22%)
What is Tempest Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of TPST is $1.54 M
What is the all time high quarterly CFF for Tempest Therapeutics?
Tempest Therapeutics all-time high quarterly cash flow from financing activities is $40.96 M
What is Tempest Therapeutics quarterly CFF year-on-year change?
Over the past year, TPST quarterly cash flow from financing activities has changed by +$1.52 M (+7238.10%)
What is Tempest Therapeutics TTM cash flow from financing activities?
The current TTM CFF of TPST is $40.90 M
What is the all time high TTM CFF for Tempest Therapeutics?
Tempest Therapeutics all-time high TTM cash flow from financing activities is $59.07 M
What is Tempest Therapeutics TTM CFF year-on-year change?
Over the past year, TPST TTM cash flow from financing activities has changed by +$44.37 M (+1277.57%)